MSB 3.42% $1.21 mesoblast limited

Cell Therapy News/Articles, page-8245

  1. 12,359 Posts.
    lightbulb Created with Sketch. 1105
    Hi Woody,
    I dont think the FDA can sign off on a Trial design .
    Then after years of effort and millions of dollars spent , say sorry we
    have changed the terms.

    SI knows this and we will get approval possibly with a adult GvHD trial to confirm.
    Which is great , take the whole market.

    He mentioned 6 months hold up and I think we have 3 months pass.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.